Rare form of leukemia found to originate in stem cells

February 13, 2014 by Bob Yirka, Medical Xpress report
A Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikipedia

(Medical Xpress)—An international team of researchers working out of the University of Toronto has found that one type of rare leukemia appears to get its start in stem cells. In their paper published in the journal Nature, the team describes how they were able to identify haematopoietic stem cells and what it may mean for future treatment of the cancer. Nicole Potter and Mel Greaves offer an in-depth explanation of the work done by the team in a News & Views piece in the same journal.

Leukemia is cancer of the bone marrow or blood—it presents itself as an overabundance of white blood cells that have not matured. Because they are not able to carry out normal blood functions, the patient, if left untreated, dies because the properly functioning cells are crowded out by the cancerous cells. One rare type of leukemia, called acute myeloid leukemia (AML) is unique in that it gets its start in the blood forming tissues within bone marrow—it's also particularly aggressive.

Scientists have known about stem cells that eventually form into white or red blood cells (or platelets) for a couple of decades, what's new in this study is the identification of a specific type of stem (haematopoietic) cell that appears to at times mutate, causing AML, and that it tends to appear as a result of mutations of a specific gene—DNMT3a.

Research by the team has revealed that up to 25 percent of AML patients have the mutation—they've found that in addition to causing cancerous cells to develop, it also causes the (pre-leukemic) stem cells to behave in ways similar to cells that develop into normal blood cells, which allows for surviving chemotherapy. That means that a patient diagnosed with leukemia, who goes through chemo which results in remission of the leukemia, could find themselves having a relapse—that it happens, is obviously very bad news for patients, but that the researchers have uncovered how the pre-leukemic cells come to exist and how they survive is very good news. It means that tests can be developed to look for the mutated gene and then therapies developed that can target the specific hematopoietic stem cells before they mature into cancerous cells.

Explore further: Cancer researchers discover pre-leukemic stem cell at root of AML, relapse

More information: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia, Nature (2014) doi:10.1038/nature13038

Abstract
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukaemic phase. Here, highly purified haematopoietic stem cells (HSCs), progenitor and mature cell fractions from the blood of AML patients were found to contain recurrent DNMT3A mutations (DNMT3Amut) at high allele frequency, but without coincident NPM1 mutations (NPM1c) present in AML blasts. DNMT3Amut-bearing HSCs showed a multilineage repopulation advantage over non-mutated HSCs in xenografts, establishing their identity as pre-leukaemic HSCs. Pre-leukaemic HSCs were found in remission samples, indicating that they survive chemotherapy. Therefore DNMT3Amut arises early in AML evolution, probably in HSCs, leading to a clonally expanded pool of pre-leukaemic HSCs from which AML evolves. Our findings provide a paradigm for the detection and treatment of pre-leukaemic clones before the acquisition of additional genetic lesions engenders greater therapeutic resistance.

Related Stories

Cancer researchers discover pre-leukemic stem cell at root of AML, relapse

February 12, 2014
Feb. 12, 2014) – Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers ...

KIT researchers develop artificial bone marrow

January 10, 2014
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University. The ...

New target isolated for leukemia drug development

February 11, 2014
There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher ...

Researchers discover how a mutated protein outwits evolution and fuels leukemia

June 20, 2013
Scientists have discovered the survival secret to a genetic mutation that stokes leukemia cells, solving an evolutionary riddle and paving the way to a highly targeted therapy for leukemia. In a paper published today in Cell, ...

Common blood cancer may be initiated by single mutation in bone cells

January 22, 2014
Acute myeloid leukemia (AML) is a blood cancer, but for many patients the cancer may originate from an unusual source: a mutation in their bone cells.

Could sleeping stem cells hold key to treatment of aggressive blood cancer?

July 29, 2013
Scientists studying an aggressive form of leukaemia have discovered that rather than displacing healthy stem cells in the bone marrow as previously believed, the cancer is putting them to sleep to prevent them forming new ...

Recommended for you

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

ginseng
not rated yet Feb 13, 2014

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.